18 Members•4,119 Posts

Pharma & Biotech

Eli Lilly crushes Q1 estimates, raises full-year outlook as GLP-1 sales surge

Apr 30, 2026

Emily Jarvie

Orthocell records first Canadian sales of Remplir™ in US$75m market

Apr 30, 2026

Jonathan Jackson

Immunic to present MS data, meet investors at May conferences

Apr 30, 2026

Emily Jarvie

Faron Pharmaceuticals issues warrants to IPF following convertible bond amortisation

Apr 30, 2026

Ian Lyall

Regeneron shares slide despite Q1 beat

Apr 29, 2026

Angela Harmantas

BioHarvest Sciences names co-founder Rakib as CEO in leadership transition

Apr 29, 2026

Angela Harmantas

OKYO Pharma to present at Eyecelerator, share urcosimod data at ARVO annual meeting

Apr 29, 2026

Emily Jarvie

Candel Therapeutics teams up with EVERSANA to prep for prostate cancer drug launch

Apr 29, 2026

Angela Harmantas

Futura Medical refines strategy and evolves commercial model after tough 2025

Apr 29, 2026

Ian Lyall

GSK reaffirms 2026 guidance after strong first-quarter performance

Apr 29, 2026

Ian Lyall

AstraZeneca sticks to its guns after strong first-quarter revenue growth

Apr 29, 2026

Ian Lyall

Inside Biotech: Dimerix sharpens Phase 3 pathway with ACTION3 ‘de-risking’ update

Apr 28, 2026

Lisa Uhlman

Santhera Pharmaceuticals CFO on strong FY25 performance & AGAMREE expansion

Apr 28, 2026

Stephen Gunnion

Poolbeg eyes transformative summer with POLB 001 data in prospect

Apr 28, 2026

Ian Lyall

20/20 BioLabs blood test platform targeting early detection of hard-to-screen Cancers

Apr 28, 2026

Steve Darling

Orthocell nerve repair study shows 90% treatment success rate

Apr 28, 2026

Jonathan Jackson

Genflow surges 14% as animal health giants circle canine ageing gene therapy

Apr 28, 2026

Ian Lyall

Immunic appoints Michael Panzara as CMO ahead of pivotal MS drug readout

Apr 28, 2026

Angela Harmantas

Scancell's melanoma data keeps widening the gap over standard care as phase III funding race heats up

Apr 28, 2026

Ian Lyall

Genflow widens confidentiality agreements with animal health companies over dog gene therapy data

Apr 28, 2026

Ian Lyall

Powered by RoundtableAn AI/DeFi-powered Enterprise Media Operating System. Learn more at Roundtable.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy